BBVA USA’s Cognex CGNX Stock Holding History

BBVA USA’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$288K	Sell	3,588 -450	-11%	-$38.7K	0.02%	401
2021 Q2	$339K	Buy	+4,038	New	+$327K	0.02%	397

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BBVA USA's CGNX Position: Q3 2021 in Review

BBVA USA reduced its Cognex (CGNX) stake by 11% in Q3 2021, selling an estimated $38.7K and leaving 3,588 shares worth $288K. The position accounts for 0.02% of the portfolio, ranked #401.

BBVA USA first reported a position in CGNX in Q2 2021 and has held it in 2 quarters since. The position peaked at $339K in Q2 2021. 534 funds tracked by Wall St. Rank hold CGNX as of Q3 2021.

BBVA USA held 3,588 shares of Cognex worth $288K as of Q3 2021.
BBVA USA sold 450 Cognex shares in Q3 2021, an estimated $38.7K.
Cognex made up 0.02% of BBVA USA's portfolio in Q3 2021, its #401 holding.
BBVA USA first reported a position in Cognex in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Cognex position peaked at $339K in Q2 2021.
534 funds tracked by Wall St. Rank held Cognex as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.